FDA panel reviewing Abbott heart device had 10 doctors with financial ties to suburban Chicago health giant
The FDA said nothing about the payments from the North Chicago company when the panel met to assess new technology, a "breakthrough device" for which the agency "may be willing to accept greater uncertainty" when considering risks and benefits.